As lipid-based nanoparticles continue to revolutionize therapeutic delivery, this guide will provide cutting-edge insights, emerging applications, and expert strategies to help you stay at the ...

2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought ...

A key challenge remains finding a delivery system that enables enough of the mRNA to reach target tissues safely without causing adverse effects. Lipid nanoparticles have been studied since the ...

Lipid nanoparticles (LNPs) and liposomes are lipid-based drug carriers that differ in internal formation. Liposomes have a phospholipid membrane surrounding an aqueous inner core mimicking natural ...

LNP profiler is the missing piece to better understand the factors mediating payload distribution, particle integrity, uptake and delivery allowing for rapid ... is set to become the new standard for ...

The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

NanoCalibur™ is based on an advanced microfluidic technology that can enable the controllable, precise, and reproducible synthesis of a wide range of nanoparticle types, including lipid ...

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 31, 2025 / Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP ... uptake and delivery ...

Phase Ib results show VERVE-102 reduced LDL-C levels with no serious safety issues, unlike Verve’s VERVE-101 programme.